
Destab 50mg Tablet ER
Marketer
Ryon Pharma
Salt Composition
Desvenlafaxine (50mg)
Overview Destab 50mg Tablet ER
Equilibria 50mg Extended-Release Tablets are a prescription medication indicated for the management of depressive disorders. This medication's mechanism involves elevating brain levels of serotonin and norepinephrine, neurotransmitters that promote calmness and nerve relaxation, thereby alleviating depressive symptoms. Equilibria 50mg Extended-Release Tablets are administered orally, with or without food, at the same time daily to ensure consistent serum drug levels. If a dose is missed, take it as soon as remembered; however, do not double doses. Complete the prescribed course of treatment, even if feeling improved. Abrupt discontinuation is strongly discouraged; consult your physician before stopping this medication to avoid potential symptom exacerbation. Frequently reported adverse effects include nausea, vomiting, sleep disturbances (insomnia), and constipation. Blood pressure elevation, particularly during the initial month, may occur; regular monitoring is advisable. Drowsiness and dizziness are also possible; avoid activities requiring alertness until the medication's effects are known. Report any unusual mood changes to your doctor immediately, as these could indicate suicidal ideation.
Primary Ingredients of Destab 50mg Tablet ER
No text provided to rephrase.
Uses of Destab 50mg Tablet ER
Major Depressive Disorder
Major Benefits of Destab 50mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 50mg Destab ER tablet whole; avoid chewing, crushing, or breaking it. While you can take it with or without food, consistency is key – take it at the same time each day.
Common Side effects of Destab 50mg Tablet ER:
- Anxiety
- Constipation
- Decreased appetite
- Dizziness
- Increased sweating
- Insomnia (difficulty in sleeping)
- Nausea
- Sexual dysfunction
- Vomiting
How to use Destab 50mg Tablet ER:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Destab 50mg Extended-Release Tablets can be consumed with or without food, though consistent timing is recommended.
How Destab 50mg Tablet ER works:
Destab 50mg Extended-Release tablets elevate brain levels of serotonin and noradrenaline, neurotransmitters crucial for emotional equilibrium.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Destab 50mg Extended-Release Tablets with alcohol. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
Extended-release Destab 50mg tablets may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Destab 50mg tablets are likely not suitable for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Extended-release Destab 50mg tablets can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these side effects.
KidneyCAUTION
Extended-release Destab 50mg tablets require careful administration for individuals with impaired kidney function. Dosage modification of Destab 50mg extended-release tablets might be necessary. Physician consultation is advised.
LiverCAUTION
Patients with hepatic impairment should use Destab 50mg Extended-Release tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Destab 50mg Tablet ER :
Should you forget a Destab 50mg Extended-Release Tablet, administer it immediately upon recollection. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Destab 50mg Tablet ER
| Label | Value |
|---|---|
| Chemical Category | Cyclohexanol Derivatives |
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
